A GLP-1 can make weight loss easier. It does not make protein, lifting, or clinician follow-up optional. The scale will try to take over the story. Let it. Then look at what the scale cannot show.
The weight-loss data on approved GLP-1 and GIP/GLP-1 medications is real. What gets skipped in most user conversations is the composition of that loss. Body-composition substudies do not all say the same thing, and they do not all measure skeletal muscle.
In the SURMOUNT-1 DXA substudy, about 25% of the weight lost on tirzepatide was lean mass, similar to the placebo diet group. A STEP 1 DXA analysis of semaglutide reported a higher lean share, around 40%. A 2024–2025 network meta-analysis put the typical lean share closer to 25%. Lean mass on DXA is not the same thing as contractile muscle. It also includes water, glycogen, and other fat-free tissue.
So the honest line is not “four of every ten pounds is muscle.” It is: some of the loss will be lean tissue, the share varies by drug, pace, protein, training, and how you measure, and the scale cannot tell you which kind of tissue moved.
The only way to see fat versus lean is a composition method, read over time, with a clinician who already owns the prescription. A DEXA trend is useful. It is not a monthly homework assignment and it is not a diagnosis. See how to track lean mass on GLP-1 with DEXA and what to discuss about muscle on a GLP-1.
I do not want a weight-loss app for this. I want a muscle-preservation companion sitting next to the prescriber, not instead of one.
Why Lean Tissue Can Move At All
These medications suppress appetite. Eating less is the point. In practice that often means less protein and fewer reasons to lift. When calories drop hard and resistance training is absent, lean tissue is more likely to come along for the ride. That pattern is not unique to GLP-1s. It shows up in diet and surgery studies too.
Less muscle can mean less strength and a lower resting energy need. Regain after a dose change or a stop is still mostly about appetite returning and habits slipping, not one number on a DEXA. Muscle is worth defending. It is not a guarantee the weight stays off.
Protein Is A Conversation, Not A Blog Prescription
The RDA of about 0.8 g of protein per kilogram of body weight is a deficiency floor for the general population. It is a weak target in a calorie deficit. Sports-nutrition reviews often discuss higher intakes, commonly in the 1.2–1.6 g/kg range, when the goal is holding lean tissue during weight loss. Older adults and people already lifting are usually discussed at the higher end.
Those are research ranges, not your dose. Kidney disease, diabetes, GI side effects, and the amount of food you can actually keep down all change the answer. A dietitian or the prescribing clinician should set the number.
Per-meal protein and leucine show up in muscle-protein-synthesis research as a reason to spread protein instead of saving it for one dinner. Treat that as a planning idea if food still goes down. Do not force a 40 g meal through nausea.
Supplements Are Optional And Not GLP-1-Specific
Two compounds get mentioned a lot next to muscle. Neither replaces protein or lifting, and neither has a dedicated, high-quality GLP-1 trial that I would treat as a protocol.
Creatine monohydrate is the better-studied of the two in training and deficit settings. Sports-nutrition position stands typically discuss about 3–5 g a day of the monohydrate form. There is no loading requirement. There is also no GLP-1-specific mandate. Kidney disease, pregnancy, and a clinician who already restricted your stack are stop signs. More in creatine on a GLP-1.
HMB has mixed data: some bed-rest and older-adult studies look useful, a 2025 meta-analysis in older adults lifting found only modest functional effects, and I have not seen a clean GLP-1 trial that justifies adding it by default. If someone brings it up, it belongs in the same clinician or dietitian visit as the rest of the stack. It is not a day-one requirement from a blog.
Lifting Still Has To Be Possible
Resistance training is the stimulus protein and creatine cannot replace. Two or three sessions a week is a common research pattern, not a medical order. Ask the clinician who knows your joints, blood pressure, and GI week whether you should start, keep, or pause.
Sessions do not need to be long. Full-body work on squat, hinge, push, and pull is enough for most people who can train at all. Progressive load matters more than volume. I am not going to pretend a 60-minute cortisol cutoff is a law. Stop when technique or symptoms say stop.
Food Order Is A Habit, Not A Drug
Eating the protein you can tolerate before the rest of the plate is a practical way to keep protein from losing to appetite suppression. Some meal-order studies show smaller glucose rises when protein, fat, or fiber come first. That is not a reason to treat food sequence as a second medication, and it is not a 300-calorie free lunch.
Overnight gaps and earlier meals can help some people sleep and eat enough protein. They are optional structure. They are not a fasting protocol I am writing for your body.
What Is Worth Bringing To Clinic
Most people on these drugs track body weight. Weight cannot split fat from lean. The useful extras are composition, symptoms, protein you actually ate, and the labs your clinician already ordered. I am not going to publish a private “longevity target” list for insulin or HbA1c. Very low HbA1c is not automatically better, especially on glucose-lowering drugs.
| Signal | Why it belongs in the visit | What it is not |
|---|---|---|
| Body composition | Shows whether weight change is mostly fat or lean | A monthly DEXA mandate |
| Protein and lifting log | Shows whether muscle had a chance | A license to change the dose |
| HbA1c, lipids, symptoms | The labs and side effects the prescriber already owns | A blog target such as HbA1c 4.0% |
| CK or albumin, if ordered | Context only. CK rises after hard training. Albumin is a late, nonspecific marker | A home muscle-breakdown test |
Retest cadence belongs to the clinician. Three months is a common lab interval. It is not a rule I can set from here.
What I Actually Track
GLP-1 medications handle appetite. The rest is a conversation with the prescriber plus a short list I can run without pretending I wrote a protocol for your body:
- 1Protein you can keep down.Ask for a target that fits your kidneys, GI week, and weight-loss pace. Spread it if meals still happen.
- 2Resistance work, if cleared.Two or three sessions is a common pattern. The session still has to be one you can do.
- 3Supplements only after a yes.Creatine is the better-studied assist. HMB is optional and thinner. Neither starts itself.
- 4Composition next to the scale.A DEXA or other composition method over time, plus the labs the clinic already uses.
Approved drugs in this class are tools. The next generation is still in trials. If you are tracking where the class is headed, see what retatrutide is and what to track. None of these drugs, and none of these articles, can run the prescription.
Mallet's GLP-1 path is built around a Muscle Preservation Score the scale cannot compute: protein, lifting, and composition next to the shot-day record you take back to clinic. It does not change your dose, diagnose muscle loss, or promise you will keep the weight off. Get early access →
Education only. Not medical advice. GLP-1 choice, dosing, labs, training clearance, and supplements belong with the prescribing clinician. Unapproved or compounded versions of these drugs have additional FDA-published risks.